Asset Medikal
Manufacturer and designer of sterile infusion therapy devices focused on needle-free IV connectors, extension sets, adapters, manifolds, IV filters and disinfecting caps. Operates R&D and design teams with in-house innovation, ISO 13485 certification and global distribution (50+ countries). Headquartered in San Diego (global) with manufacturing in Istanbul.
Industries
Nr. of Employees
medium (51-250)
Asset Medikal
Headquarters (global): San Diego, CA; Manufacturing: Istanbul, Turkey
Patents
Products
Needle-free IV valves (multiple displacement types)
Single-use needle-free valve connectors for IV therapy available in negative-displacement, neutral-displacement and one-way configurations for different clinical applications.
Extension sets and transfer spikes
Single-use extension sets and transfer spikes designed for secure attachment to IV bags and vials with integrated needle-free valves.
Manifold systems
Devices enabling multiple simultaneous IV drug deliveries through a single access point to support complex clinical protocols.
IV filters
Single-use filters intended to prevent particulates and microorganisms from passing through the infusion line.
Disinfecting caps and wipeable valve caps
Single-use disinfecting caps containing alcohol-saturated sponge material for disinfection of wipeable valve surfaces.
Needle-free IV valves (multiple displacement types)
Single-use needle-free valve connectors for IV therapy available in negative-displacement, neutral-displacement and one-way configurations for different clinical applications.
Extension sets and transfer spikes
Single-use extension sets and transfer spikes designed for secure attachment to IV bags and vials with integrated needle-free valves.
Manifold systems
Devices enabling multiple simultaneous IV drug deliveries through a single access point to support complex clinical protocols.
IV filters
Single-use filters intended to prevent particulates and microorganisms from passing through the infusion line.
Disinfecting caps and wipeable valve caps
Single-use disinfecting caps containing alcohol-saturated sponge material for disinfection of wipeable valve surfaces.
Services
Contract production and private labeling of infusion therapy components and devices for medical device and pharmaceutical companies.
Provision of clinical documentation, technical user guides and training resources to support product adoption and safe use.
Support for regulatory filings and maintenance of device certifications required for international markets.
Contract production and private labeling of infusion therapy components and devices for medical device and pharmaceutical companies.
Provision of clinical documentation, technical user guides and training resources to support product adoption and safe use.
Support for regulatory filings and maintenance of device certifications required for international markets.
Expertise Areas
- Infusion therapy device development
- Needle-free IV connector design
- Closed-system drug transfer and adapters
- IV manifold and multi-drug delivery systems
Key Technologies
- Needle-free IV connector technology
- Neutral and negative displacement valve design
- One-way valve and backflow control
- Closed-system bag and vial adapters
News & Updates
Scheduled participation in Hospitalar conference.
Scheduled participation in Medical Fair Asia.
Scheduled participation in CPHI Europe.
Scheduled participation in Medica trade fair.
Announcement of Saul Umbrasas as CEO and statement on strategic leadership to drive growth and innovation.
Press release describing a partnership with a US-based distributor to expand access to infusion therapy products in the US market.
Scheduled participation in Hospitalar conference.
Scheduled participation in Medical Fair Asia.
Scheduled participation in CPHI Europe.
Scheduled participation in Medica trade fair.
Announcement of Saul Umbrasas as CEO and statement on strategic leadership to drive growth and innovation.
Press release describing a partnership with a US-based distributor to expand access to infusion therapy products in the US market.